NASDAQ:IDXX - Nasdaq - US45168D1046 - Common Stock - Currency: USD
IDEXX LABORATORIES INC
NASDAQ:IDXX (2/4/2025, 8:00:02 PM)
After market: 465.03 0 (0%)465.03
-4.01 (-0.85%)
The current stock price of IDXX is 465.03 USD. In the past month the price increased by 11.91%. In the past year, price decreased by -18.73%.
Let's delve into the developments on the US markets one hour before the close of the markets on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Monday's session.
Wall Street bounced back after President Donald Trump and Mexican President Claudia Sheinbaum agreed to a one-month suspension of tariffs following Mexico's pledge to bolster its military presence at the northern borde
The company sells diagnostic equipment for veterinarians. Fourth-quarter metrics grew and beat expectations.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.64 | 223.92B | ||
ISRG | INTUITIVE SURGICAL INC | 79.08 | 206.46B | ||
BSX | BOSTON SCIENTIFIC CORP | 43.87 | 152.60B | ||
SYK | STRYKER CORP | 32.19 | 149.59B | ||
MDT | MEDTRONIC PLC | 17.33 | 116.65B | ||
BDX | BECTON DICKINSON AND CO | 18.42 | 70.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.72 | 42.07B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.6 | 39.72B | ||
RMD | RESMED INC | 27.2 | 35.30B | ||
DXCM | DEXCOM INC | 51.45 | 34.16B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.23 | 25.29B | ||
STE | STERIS PLC | 24.16 | 21.66B |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE 04092 US
CEO: Jonathan J. Mazelsky
Employees: 11000
Company Website: https://www.idexx.com/
Investor Relations: https://www.idexx.com/en/about-idexx/investors/
Phone: 12075560300
The current stock price of IDXX is 465.03 USD.
The exchange symbol of IDEXX LABORATORIES INC is IDXX and it is listed on the Nasdaq exchange.
IDXX stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for IDXX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of IDXX.
IDXX does not pay a dividend.
The PE ratio for IDXX is 41.34. This is based on the reported non-GAAP earnings per share of 11.25 and the current share price of 465.03 USD.
The outstanding short interest for IDXX is 2.13% of its float.
ChartMill assigns a technical rating of 3 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX is a bad performer in the overall market: 72.63% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to IDXX. IDXX has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 11.25. The EPS increased by 11.72% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 22.78% | ||
ROA | 26.96% | ||
ROE | 55.65% | ||
Debt/Equity | 0.44 |
ChartMill assigns a Buy % Consensus number of 77% to IDXX. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 8.26% and a revenue growth 6.44% for IDXX